富蘭克林坦伯頓全球投資系列-生技領航基金美元I(acc)股
64.94美元0.29(0.45%)
2024/05/09更新
績效 / 1月1.37%
3月0.02%
1年18.19%
晨星評等-
- 1.現金0.89%
- 2.股票13.01%
- 3.債券0.00%
- 4.其他86.10%
- 1.美國85.18%
- 2.歐洲不包含歐元區4.22%
- 3.英國3.89%
- 4.歐元區3.88%
- 5.加拿大0.98%
- 1.Amgen Inc7.08%
- 2.Regeneron Pharmaceuticals Inc6.34%
- 3.Vertex Pharmaceuticals Inc5.39%
- 4.Ascendis Pharma A/S ADR4.07%
- 5.AstraZeneca PLC ADR3.69%
- 6.Biogen Inc3.15%
- 7.Gilead Sciences Inc2.99%
- 8.Intra-Cellular Therapies Inc2.91%
- 9.Jazz Pharmaceuticals PLC2.69%
- 10.Neurocrine Biosciences Inc2.64%
- 1.現金0.89%
- 2.股票13.01%
- 3.債券0.00%
- 4.其他86.10%
- 1.美國85.18%
- 2.歐洲不包含歐元區4.22%
- 3.英國3.89%
- 4.歐元區3.88%
- 5.加拿大0.98%
- 1.Amgen Inc7.08%
- 2.Regeneron Pharmaceuticals Inc6.34%
- 3.Vertex Pharmaceuticals Inc5.39%
- 4.Ascendis Pharma A/S ADR4.07%
- 5.AstraZeneca PLC ADR3.69%
- 6.Biogen Inc3.15%
- 7.Gilead Sciences Inc2.99%
- 8.Intra-Cellular Therapies Inc2.91%
- 9.Jazz Pharmaceuticals PLC2.69%
- 10.Neurocrine Biosciences Inc2.64%